Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Aralia elata contains active compounds called aralosides, along with oleanolic acid and ursolic acid, which are believed to support blood sugar regulation through multiple pathways. These compounds may enhance insulin sensitivity and improve glucose metabolism at the cellular level. The herb also contains polysaccharides that may support pancreatic function. Research on the specific mechanism remains limited, with current evidence rated at Level C, indicating primarily animal and in vitro studies rather than robust clinical trials in humans.
Can Aralia elata interact with diabetes medications?
Yes, Aralia elata may interact with hypoglycemic medications. Because this herb has blood sugar-lowering properties, taking it alongside diabetes medications such as metformin, insulin, or sulfonylureas could potentially cause additive effects, leading to hypoglycemia (dangerously low blood sugar). Symptoms may include dizziness, confusion, sweating, and weakness. If you are taking prescription medications for diabetes, consult a qualified healthcare provider before using Aralia elata. Regular blood glucose monitoring is essential when combining herbal supplements with diabetes medications.
What is the recommended daily dosage for Aralia elata?
Traditional use and available evidence suggest an adult dosage of 6 to 12 grams of dried bark or root as a decoction daily. Alternatively, standardized extracts are commonly taken at approximately 300 mg per day. However, optimal dosing has not been established through rigorous clinical trials, and evidence quality remains at Level C. Dosage may vary based on the specific preparation, concentration of active compounds, and individual health status. Always follow product label instructions or consult a healthcare professional for personalized guidance.
Is Aralia elata safe to take during pregnancy and breastfeeding?
Aralia elata is considered unsafe during pregnancy and should be avoided. There is insufficient safety data regarding its use in pregnant or breastfeeding women, and traditional sources contraindicate its use in these populations. Some compounds in Aralia species may stimulate uterine contractions or affect hormonal balance. Due to the lack of safety evidence and potential risks, pregnant and nursing women should not use this herb. Consult a qualified healthcare provider for safe alternatives to manage fatigue or other health concerns during pregnancy.
What are the traditional uses of Aralia elata in Korean and Japanese medicine?
Aralia elata has been used traditionally in Korean and Japanese medicine for centuries as an adaptogenic tonic to combat fatigue and support overall vitality. It has been employed to address rheumatism and joint inflammation, support liver function, and help regulate blood sugar levels. The herb is classified as an anti-inflammatory and adaptogenic remedy in traditional practice. Current scientific evidence supporting these traditional uses is rated at Level C, meaning most data comes from preliminary research rather than well-designed human clinical trials.
What side effects can Aralia elata cause?
Reported side effects of Aralia elata are generally mild but may include nausea and gastrointestinal discomfort. Because the herb can lower blood sugar levels, hypoglycemia is a potential concern, particularly in individuals with diabetes or those taking blood sugar-lowering medications. Symptoms of low blood sugar include shakiness, sweating, confusion, and dizziness. Those with known allergies to plants in the Araliaceae family should exercise caution. If you experience any adverse effects, discontinue use and consult a healthcare provider.
Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Aralia elata is a perennial woody plant of the Araliaceae family used in East Asian traditional medicine for its pharmacological effects [PMID:35300010, PMID:37916310].
Contexte
Aralia elata (also known as Aralia mandshurica) is a woody plant species found in Northeastern Asia, particularly in China, Japan, and Korea [PMID:37916310, PMID:38485062]. It is closely related to Panax ginseng and is utilized as both a medicinal herb and a wild edible vegetable [PMID:39632860, PMID:42294140].
Usages traditionnels
In traditional Chinese medicine, it is used to 'tonify Qi and calm the mind, strengthen the essence and tonify the kidneys, and dispel wind and invigorate blood circulation' [PMID:37916310]. It has been used to treat neurasthenia, Yang deficiency, Qi deficiency, kidney Qi deficiency, spleen Yang deficiency, water-dampness stagnation, thirst, bruises, diabetes, rheumatoid arthritis, asthma, cough, and phlegm [PMID:37916310, PMID:33438534, PMID:39122067, PMID:41786057].
Composés actifs
The primary active components are triterpenoid saponins (including elatosides and araloside A), polysaccharides (composed of Gal, Glc, Man, Ara, and Rha), and flavonoids [PMID:37916310, PMID:37436646, PMID:39122067, PMID:39731422, PMID:42294140]. Flower essential oil (AESFEO) also contains bioactive components [PMID:39204353].
Mécanisme d'action
Araloside A induces autophagy via a Raf/MEK/ERK-dependent manner to clear APP, total Tau, phosphorylated Tau, and α-synuclein [PMID:40742404]. Total saponins may alleviate myocardial ischemia-reperfusion injury by promoting NLRP3-inflammasome inactivation via PI3K/Akt signaling [PMID:36408810]. Flower essential oil promotes proliferation and type IV collagen production in keratinocytes by enhancing phosphorylation of Erk1/2, p38 MAPK, JNK, and Akt [PMID:39204353].
Preuves cliniques
Preuve DMyocardial Ischemia-Reperfusion Injury
Total saponins (TSAE) alleviate injury by promoting NLRP3-inflammasome inactivation via PI3K/Akt signaling in rat models [PMID:36408810]
Preuve DNeurodegenerative Pathology (AD/PD)
Araloside A (ARA) promotes autophagosome formation and reduces cytotoxicity in neuronal cell and C. elegans models [PMID:40742404]
Preuve DSkin Wound Healing/Whitening
Flower essential oil (AESFEO) promotes keratinocyte proliferation and reduces melanin synthesis in B16BL6 cells [PMID:39204353]
Preuve DAsthma
Total glycosides (GA) show potential in ameliorating airway inflammation and mucus hypersecretion in asthmatic mice [PMID:41786057]
The current evidence consists primarily of in vitro cell studies, animal models, and literature reviews. There are no human clinical trials provided in the abstracts.
Sources PubMed
1.PMID: 36387605 (2023) — Cut-dip-budding delivery system enables genetic modifications in plants without tissue culture. · Innovation (Cambridge (Mass.))
2.PMID: 37916310 (2023) — Research progress in pharmacological effects of Aralia elata. · Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
3.PMID: 37436646 (2023) — New biofunctional effects of oleanane-type triterpene saponins. · Journal of natural medicines
4.PMID: 39204353 (2024) — Potential Wound Healing and Anti-Melanogenic Activities in Skin Cells of Aralia elata (Miq.) Seem. Flower Essential Oil and Its Chemical Composition. · Pharmaceutics
5.PMID: 27765361 (2016) — Aralia elata var. mandshurica (Rupr. & Maxim.) J.Wen: An overview of pharmacological studies.
Sources gouvernementales
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.
· Phytomedicine : international journal of phytotherapy and phytopharmacology
6.PMID: 27859496 (2017) — Application of a solvent-free solid injection technique coupled with GC-MS for discrimination between the secondary metabolites of wild and cultivated South Korean medicinal foods. · Biomedical chromatography : BMC
7.PMID: 39632860 (2024) — Cytogenomic evaluation of regenerated Aralia elata using PLOP-FISH and flow cytometry. · Scientific reports
8.PMID: 33438534 (2021) — A Review on a Medicinal and Edible Plant: Aralia elata (Miq.) Seem. · Mini reviews in medicinal chemistry
9.PMID: 42294140 (2026) — Characterization of saponin biotransformation driven by intrinsic proteins in Aralia elata leaves. · Food chemistry: X
10.PMID: 39122067 (2024) — A mini-review of isolation, purification, structural characteristics and bioactivities of polysaccharides from Aralia elata (Miq.) Seem. · International journal of biological macromolecules
11.PMID: 35300010 (2022) — A High-Quality Reference Genome Sequence and Genetic Transformation System of Aralia elata. · Frontiers in plant science
12.PMID: 40742404 (2025) — Araloside A Induces Raf/MEK/ERK-Dependent Autophagy to Mitigate Alzheimer's and Parkinson's Pathology in Cellular and C. elegans Models. · Molecular neurobiology
13.PMID: 38485062 (2024) — A comprehensive analysis integrating phenotypic assessment uncovering thornless cultivar lineages in Aralia elata. · Genomics
14.PMID: 39731422 (2025) — Extraction and biological activities of polysaccharides and saponins from Aralia elata: a review. · Natural product research
15.PMID: 41786057 (2026) — Ameliorative effects of total glycosides from Aralia elata on airway inflammation and mucus hypersecretion in asthmatic mice. · Journal of ethnopharmacology
16.PMID: 36408810 (2023) — Total saponins of Aralia elata (Miq.) Seem. alleviate myocardial ischemia-reperfusion injury by promoting NLRP3-inflammasome inactivation via PI3K/Akt signaling. · The Kaohsiung journal of medical sciences
17.PMID: 38360127 (2024) — Functional identification of AeHMGR gene involved in regulation of saponin biosynthesis in Aralia elata. · Gene